feed,title,long_url,short_url
SeekingAlpha,Bristol Myers' deucravacitinib tops Amgen's Otezla in late-stage psoriasis study,https://seekingalpha.com/news/3630264,
SeekingAlpha,Fuchs Petrolub reports Q3 results,https://seekingalpha.com/news/3630263,
SeekingAlpha,"Catalent EPS beats by $0.06, beats on revenue",https://seekingalpha.com/news/3630262,
